We are live on ! Find out more
KEQU icon

Kewaunee Scientific

18 hedge funds and large institutions have $17.2M invested in Kewaunee Scientific in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $16.2M → $17.2M (+$937K)

0.91% less ownership

Funds ownership: 35.26%34.35% (-0.91%)

5% less funds holding

Funds holding: 1918 (-1)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
4
Reduced
6
Closed
1
Calls
Puts
Net Calls
Net Calls Change

KEQU Hedge Fund Activity: Q3 2022 in Review

18 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Kewaunee Scientific (KEQU) for Q3 2022, worth a combined $17.2M — up 5.8% from $16.2M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of KEQU and 0 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $13.6K. The largest seller was Renaissance Technologies, cutting an estimated $121K.

  • 18 institutional investors held Kewaunee Scientific (KEQU) as of Q3 2022, down from 19 in Q2 2022.
  • Funds reported $17.2M of Kewaunee Scientific stock for Q3 2022, up 5.8% quarter-over-quarter.
  • 0 funds opened new Kewaunee Scientific positions in Q3 2022 and 1 closed out, a net change of -1 holder.
  • The largest Kewaunee Scientific buyer in Q3 2022 was Dimensional Fund Advisors, an estimated $13.6K added.
  • The largest Kewaunee Scientific seller in Q3 2022 was Renaissance Technologies, an estimated $121K sold.

Based on aggregated 13F filings for Q3 2022.